Combination treatment of transforming growth factor-β blocker with EcN appeared to restore tumor-infiltrating CTL-disrupted cancer cells and increased the proportion of tumor-infiltrating CD3+CD8+IFN-γ+CTL (Table 1) (Shi, et al., 2019). The gene discussed is CD8A; the disease is neoplasm.